Clinical Trials Insight: 700019267
Phase of Trial: Phase I
Latest Information Update: 05 Dec 2008
At a glance
- Drugs AZD 2836 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Arrow Therapeutics
- 05 Dec 2008 Status changed from recruiting to unconfirmed as reported by an AstraZeneca representative (New Zealand).
- 29 Nov 2006 New trial record.